verapamil has been researched along with iloprost in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Criddle, DN; Dewar, GH; Wathey, WB; Woodward, B | 1 |
| Demirel, E; Türker, RK | 1 |
| Alvarez-Lopez, A; de Hemptinne, B; Hoebeke, Y; Lambotte, L | 1 |
| Tiegs, G; Wendel, A; Wolter, M | 1 |
| Dettmer, D; Drews, G; Hauss, J; Hermsdorf, T; Richter, V; Spiegel, HU | 1 |
| Israeli, D; Senderoff, DM; Urken, ML; Weinberg, H; Zhang, WX | 1 |
| Aktan, AO; Büyükgebiz, O; Ercan, S; Haklar, G; Yalçin, AS; Yalin, R; Yeğen, C | 1 |
| Aktan, AO; Döşlüoğlu, HH; Ercan, S; Okboy, N; Yahn, R; Yalçm, AS; Yeğen, C | 1 |
| Abe, A; Hori, M; Karaki, H; Kinoshita, M; Mitsui-Saito, M; Ozaki, H; Uehigashi, Y | 1 |
| Lazareth, I | 1 |
1 review(s) available for verapamil and iloprost
| Article | Year |
|---|---|
[Management of Raynaud's phenomenon].
Topics: Adult; Age Distribution; Calcium Channel Blockers; Female; Humans; Iloprost; Losartan; Male; Middle Aged; Necrosis; Prognosis; Raynaud Disease; Risk Factors; Sex Distribution; Smoking; Vasodilator Agents; Verapamil | 2001 |
11 other study(ies) available for verapamil and iloprost
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The effects of novel vasodilator long chain acyl carnitine esters in the isolated perfused heart of the rat.
Topics: Animals; Benzopyrans; Carnitine; Coronary Circulation; Cromakalim; Dose-Response Relationship, Drug; Epoprostenol; Heart; Iloprost; In Vitro Techniques; Male; Myocardial Contraction; Nitrates; Palmitoylcarnitine; Pentanols; Pyrroles; Rats; Rats, Inbred Strains; Vasodilator Agents; Verapamil | 1990 |
Inhibition of iloprost of the contractile effect of noradrenaline in mesenteric artery rings: evidence for a possible calcium-dependent mechanism.
Topics: Animals; Aorta, Thoracic; Calcium; Drug Interactions; Endothelium, Vascular; Female; Iloprost; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenoxybenzamine; Rabbits; Receptors, Adrenergic; Verapamil | 1991 |
Prostaglandin E2 increases the tolerance of the rat liver to warm ischemia in absence of splanchnic congestion.
Topics: Animals; Dinoprostone; Epoprostenol; Iloprost; Ischemia; Liver; Liver Circulation; Organ Preservation; Prostaglandins E; Rats; Splanchnic Circulation; Superoxide Dismutase; Temperature; Verapamil | 1987 |
Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
Topics: Allopurinol; Animals; Chemical and Drug Induced Liver Injury; Eicosanoic Acids; Endotoxins; Epoprostenol; Galactosamine; Iloprost; Imidazoles; Male; Mice; Mice, Inbred Strains; Nifedipine; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Verapamil; Xanthine Oxidase | 1989 |
Cytoprotective effects of a stable prostacyclin analog and a calcium channel blocker: a study on isolated rat hepatocytes.
Topics: Adenosine; Allopurinol; Animals; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Cryoprotective Agents; Female; Glutathione; Iloprost; Insulin; L-Lactate Dehydrogenase; Liver; Malondialdehyde; Organ Preservation Solutions; Raffinose; Rats; Rats, Wistar; Tissue Preservation; Verapamil | 1995 |
Enhancement of fluorescein perfusion in experimental skin flaps following postischemic washout with iloprost, urokinase, verapamil, and University of Wisconsin solution.
Topics: Adenosine; Allopurinol; Animals; Female; Fluorescein; Fluoresceins; Glutathione; Iloprost; Insulin; Ischemia; Organ Preservation Solutions; Perfusion; Raffinose; Rats; Rats, Sprague-Dawley; Skin; Surgical Flaps; Tissue Preservation; Urokinase-Type Plasminogen Activator; Verapamil | 1993 |
Effect of verapamil and iloprost (ZK 36374) on endothelin release after mesenteric ischemia-reperfusion injury.
Topics: Animals; Dinoprostone; Endothelins; Female; Iloprost; Intestinal Mucosa; Leukotriene C4; Malondialdehyde; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Splanchnic Circulation; Verapamil | 1994 |
The cytoprotective effects of verapamil and iloprost (ZK 36374) on ischemia/reperfusion injury of kidneys.
Topics: Animals; Creatinine; Glutathione; Iloprost; Ischemia; Kidney; Male; Malondialdehyde; Rats; Rats, Wistar; Reperfusion Injury; Verapamil | 1993 |
Effects of a prostaglandin I2 analog iloprost on cytoplasmic Ca2+ levels and muscle contraction in isolated guinea pig aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Calcium; Cyclic AMP; Dinoprost; Dose-Response Relationship, Drug; Guinea Pigs; Iloprost; In Vitro Techniques; Indomethacin; Male; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstriction; Verapamil | 1996 |